Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience

Background: Despite the effectiveness of several biological agents in the treatment of inflammatory bowel disease (IBD), some patients respond better than others. Such discrepancies are often evident early in the treatment course. The aim of this study is to identify the risks and assess the rate of...

Descripció completa

Dades bibliogràfiques

Autors principals:	Maheeba Abdulla, Jehad AlQamish, Nafeesa Mohammed, Mahmood Al Saeed, Hasan Jawad Al Aali, Aysha Al Khaja, Zahra Abdulla Isa Yusuf Hasan, Fatema Yusuf Haider, Sayed Dhiyaa Noor Ebrahim, Zahra Sayed Alawi Mahfoodh, Mahmood Ali Hasan Hubail, Isa Alhajri, Fatema Al-Matrook, Ahmed Tork
Format:	Artigo
Idioma:	Inglês
Publicat:	Wolters Kluwer Medknow Publications 2022-01-01
Col·lecció:	The Saudi Journal of Gastroenterology
Matèries:	biological therapy crohn's disease inflammatory bowel diseases ulcerative colitis
Accés en línia:	http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2022;volume=28;issue=3;spage=193;epage=200;aulast=Abdulla
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!